Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingeborg M Bachmann

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|May 12, 2026
Petter Gjersvik, Ingeborg M Bachmann
International Journal of Oncology|November 18, 2004
Altered expression of cell cycle regulators Cyclin D1, p14, p16, CDK4 and Rb in nodular melanomasIngeborg M Bachmann, Oddbjørn Straume, Lars A Akslen
The Journal of Investigative Dermatology|February 3, 2012
Prognostic importance of the mitotic marker phosphohistone H3 in cutaneous nodular melanomaRita G Ladstein, Ingeborg M Bachmann, Oddbjørn Straume, et al.
BMC Cancer|April 20, 2010
Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanomaRita G Ladstein, Ingeborg M Bachmann, Oddbjørn Straume, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 14, 2013
Nestin expression is associated with aggressive cutaneous melanoma of the nodular typeRita G Ladstein, Ingeborg M Bachmann, Oddbjørn Straume, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 5, 2008
Loss of BMI-1 expression is associated with clinical progress of malignant melanomaIngeborg M Bachmann, Hanne E Puntervoll, Arie P Otte, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|March 24, 2023
Expression of β-Catenin, E-Cadherin, and α-Smooth Muscle Actin in Basal Cell Carcinoma Before Photodynamic Therapy in Non-recurrent and Recurrent Tumors: Exploring the Ability of Predicting Photodynamic Therapy OutcomeErik Mørk, Patricia Mjønes, Olav A Foss, et al.
Plos One|January 15, 2019
Prognostic value of uPAR expression and angiogenesis in primary and metastatic melanomaEmilia Hugdahl, Ingeborg M Bachmann, Cornelia Schuster, et al.
BMC Cancer|December 9, 2008
Tumor necrosis is associated with increased alphavbeta3 integrin expression and poor prognosis in nodular cutaneous melanomasIngeborg M Bachmann, Rita G Ladstein, Oddbjørn Straume, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2005
Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanomaIngeborg M Bachmann, Oddbjørn Straume, Hanne E Puntervoll, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|May 12, 2026
Petter Gjersvik, Ingeborg M Bachmann
International Journal of Oncology|November 18, 2004
Altered expression of cell cycle regulators Cyclin D1, p14, p16, CDK4 and Rb in nodular melanomasIngeborg M Bachmann, Oddbjørn Straume, Lars A Akslen
The Journal of Investigative Dermatology|February 3, 2012
Prognostic importance of the mitotic marker phosphohistone H3 in cutaneous nodular melanomaRita G Ladstein, Ingeborg M Bachmann, Oddbjørn Straume, et al.
BMC Cancer|April 20, 2010
Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanomaRita G Ladstein, Ingeborg M Bachmann, Oddbjørn Straume, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 14, 2013
Nestin expression is associated with aggressive cutaneous melanoma of the nodular typeRita G Ladstein, Ingeborg M Bachmann, Oddbjørn Straume, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 5, 2008
Loss of BMI-1 expression is associated with clinical progress of malignant melanomaIngeborg M Bachmann, Hanne E Puntervoll, Arie P Otte, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|March 24, 2023
Expression of β-Catenin, E-Cadherin, and α-Smooth Muscle Actin in Basal Cell Carcinoma Before Photodynamic Therapy in Non-recurrent and Recurrent Tumors: Exploring the Ability of Predicting Photodynamic Therapy OutcomeErik Mørk, Patricia Mjønes, Olav A Foss, et al.
Plos One|January 15, 2019
Prognostic value of uPAR expression and angiogenesis in primary and metastatic melanomaEmilia Hugdahl, Ingeborg M Bachmann, Cornelia Schuster, et al.
BMC Cancer|December 9, 2008
Tumor necrosis is associated with increased alphavbeta3 integrin expression and poor prognosis in nodular cutaneous melanomasIngeborg M Bachmann, Rita G Ladstein, Oddbjørn Straume, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2005
Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanomaIngeborg M Bachmann, Oddbjørn Straume, Hanne E Puntervoll, et al.
Pageof 2